The energetics of Huntington's disease
- PMID: 15038601
- DOI: 10.1023/b:nere.0000014824.04728.dd
The energetics of Huntington's disease
Abstract
Huntington's disease (HD) is a hereditary neurodegenerative disorder that gradually robs sufferers of the ability to control movements and induces psychological and cognitive impairments. This devastating, lethal disease is one of several neurological disorders caused by trinucleotide expansions in affected genes, including spinocerebellar ataxias, dentatorubral-pallidoluysian atrophy, and spinal bulbar muscular atrophy. HD symptoms are associated with region-specific neuronal loss within the central nervous system, but to date the mechanism of this selective cell death remains unknown. Strong evidence from studies in humans and animal models suggests the involvement of energy metabolism defects, which may contribute to excitotoxic processes, oxidative dmage, and altered gene regulation. The development of transgenic mouse models expressing the human HD mutation has provided novel opportunities to explore events underlying selective neuronal death in HD, which has hitherto been impossible in humans. Here we discuss how animal models are redefining the role of energy metabolism in HD etiology.
Similar articles
-
Glucose transportation in the brain and its impairment in Huntington disease: one more shade of the energetic metabolism failure?Amino Acids. 2017 Jul;49(7):1147-1157. doi: 10.1007/s00726-017-2417-2. Epub 2017 Apr 10. Amino Acids. 2017. PMID: 28396959 Review.
-
Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.Ann N Y Acad Sci. 2008 Dec;1147:358-82. doi: 10.1196/annals.1427.018. Ann N Y Acad Sci. 2008. PMID: 19076457 Review.
-
Oxidative damage in Huntington's disease pathogenesis.Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):2061-73. doi: 10.1089/ars.2006.8.2061. Antioxid Redox Signal. 2006. PMID: 17034350 Review.
-
Bioenergetics in Huntington's disease.Ann N Y Acad Sci. 1999;893:203-13. doi: 10.1111/j.1749-6632.1999.tb07827.x. Ann N Y Acad Sci. 1999. PMID: 10672239 Review.
-
Oxidative stress in Huntington's disease.Brain Pathol. 1999 Jan;9(1):147-63. doi: 10.1111/j.1750-3639.1999.tb00216.x. Brain Pathol. 1999. PMID: 9989457 Free PMC article. Review.
Cited by
-
Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington's disease.Arch Pharm Res. 2024 Jun;47(6):571-595. doi: 10.1007/s12272-024-01499-w. Epub 2024 May 19. Arch Pharm Res. 2024. PMID: 38764004 Review.
-
Neuropathogenesis-on-chips for neurodegenerative diseases.Nat Commun. 2024 Mar 12;15(1):2219. doi: 10.1038/s41467-024-46554-8. Nat Commun. 2024. PMID: 38472255 Free PMC article. Review.
-
Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington's Disease.Antioxidants (Basel). 2023 Feb 24;12(3):571. doi: 10.3390/antiox12030571. Antioxidants (Basel). 2023. PMID: 36978821 Free PMC article. Review.
-
Vitamin B6, B12 and folate modulate deregulated pathways and protein aggregation in yeast model of Huntington disease.3 Biotech. 2023 Mar;13(3):96. doi: 10.1007/s13205-023-03525-y. Epub 2023 Feb 24. 3 Biotech. 2023. PMID: 36852176 Free PMC article.
-
Modulation of Synaptic Plasticity Genes Associated to DNA Damage in a Model of Huntington's Disease.Neurochem Res. 2023 Jul;48(7):2093-2103. doi: 10.1007/s11064-023-03889-w. Epub 2023 Feb 15. Neurochem Res. 2023. PMID: 36790580
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical